We speak to Andrew MacIsaac, CEO of Applied Pharmaceutical Innovation (API) about supporting the life sciences sector by linking post-secondary institutions and industry and facilitating commercialization. We also talk about the Canadian Critical Drug Initiative and the work being done to build the Edmonton region into a pharmaceutical R & D and manufacturing hub. 

Applied Pharmaceutical Innovation: https://appliedpharma.ca/ 
Andrew can be followed on Twitter: @andrewkm